Bal is an experienced patent attorney and has worked within the pharmaceutical field for over 20 years. He has a strong technical background and has held senior roles within both the R&D and IP functions of global pharmaceutical and drug delivery companies.
During his career he has built and defended patent portfolios protecting products at all stages of development, including a range of high-profile on-market medicines.
Bal has a first degree in Pharmacy and a PhD in drug delivery and started his career with AstraZeneca as a senior product development scientist. During his time in this role, he led several technical programs to develop and repurpose drug candidates and is an inventor on patents protecting one of AZ’s oncology medicines.
In 2006, Bal transitioned into the IP department of AZ and progressed to the role of senior patent attorney. He has managed global patent portfolios protecting key products and he has also led IP due diligence activities for licensing and late-stage acquisitions. During his last 3 years at AZ, Bal was seconded into the litigation group to defend patents protecting a CNS product in multiple jurisdictions across Europe, South America and Asia.
Bal has developed an in-depth knowledge of the strategic aspects of multi-jurisdictional pharmaceutical patent litigation and also regularly acts as lead counsel in European patent opposition and appeal proceedings.
Since joining HGF, Bal has used his patent expertise and understanding of drug discovery and development to help clients focus their IP activities and achieve their commercial objectives.
Biopharmaceutics and Drug Delivery
September 22nd 2022
March 14th 2019
Visiting lecturer at King’s College London and contribute to drug development modules of MPharm Pharmacy degree course.
Mentoring trainee patent attorneys.
Previously lectured on JDD course for EQE qualifications.
Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …Event details
The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …Read article
Time: 14.00 – 15.00 UTC HGF Patent Director, Dr Janine Swarbrick will be speaking on the upcoming Lexology webinar: Across Continents: Exploring Common Ground and Contrasts in Patenting Software Inventions …Event details
We are happy to announce the Leaders League rankings for 2023 are now live, and HGF is basking in the spotlight with multiple mentions across various categories. This recognition reaffirms …Read article
Any electronic communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them. This means that electronic correspondence are …Read article
HGF is organising a German-speaking seminar series in Salzburg, Dresden, and Hamburg. Dates September 5, 2023 at 17:30 – Dresden September 7, 2023 at 17:30 – Hamburg – CANCELLED September …Event details
HGF is delighted to be ranked Tier 1 and Tier 2, and highly recommended in the latest Managing Intellectual Property firm rankings for patent work. Managing Intellectual Property has published …Read article
IAM Patent 1000 the world’s leading patent professionals 2023 guide has now been published and we are delighted to have 31 attorneys recognised as world-class individuals in the guide. The …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.